BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18755885)

  • 1. Altered bone mass, geometry and mechanical properties during the development and progression of type 2 diabetes in the Zucker diabetic fatty rat.
    Prisby RD; Swift JM; Bloomfield SA; Hogan HA; Delp MD
    J Endocrinol; 2008 Dec; 199(3):379-88. PubMed ID: 18755885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel rat model for the study of deficits in bone formation in type-2 diabetes.
    Liu Z; Aronson J; Wahl EC; Liu L; Perrien DS; Kern PA; Fowlkes JL; Thrailkill KM; Bunn RC; Cockrell GE; Skinner RA; Lumpkin CK
    Acta Orthop; 2007 Feb; 78(1):46-55. PubMed ID: 17453392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
    Facchini DM; Yuen VG; Battell ML; McNeill JH; Grynpas MD
    Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.
    Sugimoto K; Rashid IB; Kojima K; Shoji M; Tanabe J; Tamasawa N; Suda T; Yasujima M
    Diabetes Metab Res Rev; 2008; 24(8):642-50. PubMed ID: 18973207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density and bone metabolism in diabetes mellitus.
    Piepkorn B; Kann P; Forst T; Andreas J; Pfützner A; Beyer J
    Horm Metab Res; 1997 Nov; 29(11):584-91. PubMed ID: 9479561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mass in obese diabetic Zucker rats: influence of treadmill running.
    Mathey J; Horcajada-Molteni MN; Chanteranne B; Picherit C; Puel C; Lebecque P; Cubizoles C; Davicco MJ; Coxam V; Barlet JP
    Calcif Tissue Int; 2002 Apr; 70(4):305-11. PubMed ID: 12004335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function.
    Hamann C; Goettsch C; Mettelsiefen J; Henkenjohann V; Rauner M; Hempel U; Bernhardt R; Fratzl-Zelman N; Roschger P; Rammelt S; Günther KP; Hofbauer LC
    Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1220-8. PubMed ID: 21900121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Mellitus: Does it Affect Bone?
    Schwartz AV
    Calcif Tissue Int; 2003 Dec; 73(6):515-9. PubMed ID: 14517715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic gluconeogenesis is enhanced in renal proximal tubules of Zucker diabetic fatty rats.
    Eid A; Bodin S; Ferrier B; Delage H; Boghossian M; Martin M; Baverel G; Conjard A
    J Am Soc Nephrol; 2006 Feb; 17(2):398-405. PubMed ID: 16396963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of parathyroid hormone on bone mass, bone strength, and bone regeneration in male rats with type 2 diabetes mellitus.
    Hamann C; Picke AK; Campbell GM; Balyura M; Rauner M; Bernhardt R; Huber G; Morlock MM; Günther KP; Bornstein SR; Glüer CC; Ludwig B; Hofbauer LC
    Endocrinology; 2014 Apr; 155(4):1197-206. PubMed ID: 24467747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of severe diabetes and insulin on the femoral neck of the immature rat.
    Hou JC; Zernicke RF; Barnard RJ
    J Orthop Res; 1993 Mar; 11(2):263-71. PubMed ID: 8483039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus, bone mineral density, and fracture risk.
    Strotmeyer ES; Cauley JA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):429-35. PubMed ID: 17982347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mineral and mechanical properties of bone in chronic experimental diabetes.
    Einhorn TA; Boskey AL; Gundberg CM; Vigorita VJ; Devlin VJ; Beyer MM
    J Orthop Res; 1988; 6(3):317-23. PubMed ID: 3258636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histomorphometric evaluation of the influence of the diabetic metabolic state on bone defect healing depending on the defect size in spontaneously diabetic BB/OK rats.
    Follak N; Klöting I; Wolf E; Merk H
    Bone; 2004 Jul; 35(1):144-52. PubMed ID: 15207750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus.
    Hamann C; Rauner M; Höhna Y; Bernhardt R; Mettelsiefen J; Goettsch C; Günther KP; Stolina M; Han CY; Asuncion FJ; Ominsky MS; Hofbauer LC
    J Bone Miner Res; 2013 Mar; 28(3):627-38. PubMed ID: 23109114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal involvement in patients with diabetes mellitus.
    Carnevale V; Romagnoli E; D'Erasmo E
    Diabetes Metab Res Rev; 2004; 20(3):196-204. PubMed ID: 15133750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats.
    Erdal N; Gürgül S; Kavak S; Yildiz A; Emre M
    Biol Trace Elem Res; 2011 Jun; 140(3):342-53. PubMed ID: 20446056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of bone structural and material properties on bone competence in C57BL/6 and C3H/He inbred strains of mice.
    Voide R; van Lenthe GH; Müller R
    Calcif Tissue Int; 2008 Jul; 83(1):61-9. PubMed ID: 18545865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyl-CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes.
    Kreuz S; Schoelch C; Thomas L; Rist W; Rippmann JF; Neubauer H
    Diabetes Metab Res Rev; 2009 Sep; 25(6):577-86. PubMed ID: 19618481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.